Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.
about
Potential therapeutic targets for neurokinin-1 receptor antagonistsThe trigeminovascular system in bacterial meningitis.RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks.A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasationPeripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulationGABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges.Evidence based medicine on the use of botulinum toxin for headache disorders.Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat.Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headache.Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea-pig conjunctiva.Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.Inhibition of bradykinin-evoked trigeminal nerve stimulation by the non-peptide bradykinin B2 receptor antagonist WIN 64338 in vivo and in vitro.Increased metabolite concentration in migraine rat model by proton MR spectroscopy in vivo and ex vivo.An update and systematic review on drug therapies for the treatment of refractory chronic cough.
P2860
Q28262693-31DFD7C1-8D41-4297-9177-D460163889B8Q34218327-0E026352-1DFA-4925-A89C-A46F877745B4Q34648375-C15788D8-7960-4995-8AC4-ED5F12E10AB1Q35693015-6D057700-47D1-43F8-83DB-245CFDC65FC9Q35872756-DF89D8A7-1E2B-43ED-87DE-822704B64CEAQ35873339-3AA5388C-2559-4BB7-AC64-22054029AF1AQ36997741-11289C6F-8BFF-47D8-8270-EF74187F1A90Q39449767-95DCCA25-A825-4ADE-AEF2-DA209EA1171CQ41143409-CA2A2206-7B34-4103-AA12-34E750B8BF06Q41998317-037F647E-8B48-43F0-9033-28C167D49251Q42116885-85D7F815-CCDD-434C-91BF-0C4BC74A96DAQ42706978-A839A705-D6E7-40FB-A272-3BA80B5033D0Q46304629-009733C3-A839-449B-9B43-918EA57589E4Q52586592-4BF9D1BE-0A89-4DAC-BF80-B504E47D04A7
P2860
Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@ast
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@en
Blockade by oral or parenteral RPR 100893
@nl
type
label
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@ast
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@en
Blockade by oral or parenteral RPR 100893
@nl
prefLabel
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@ast
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@en
Blockade by oral or parenteral RPR 100893
@nl
P2093
P2860
P1476
Blockade by oral or parenteral ...... ig dura mater and conjunctiva.
@en
P2093
Moskowitz MA
Moussaoui SM
P2860
P304
P356
10.1111/J.1476-5381.1994.TB13168.X
P407
P577
1994-07-01T00:00:00Z